<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">LORACARBEF</span><br/>(lor-a-car'bef)<br/><span class="topboxtradename">Lorabid<br/></span><b>Classifications:</b> <span class="classification">antiinfective</span>; <span class="classification">antibiotic</span>; <span class="classification">beta-lactam</span><br/><b>Prototype: </b>Cefonicid<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>200 mg, 400 mg capsules; 100 mg/5 mL, 200 mg/5 mL suspension</p>
<h1><a name="action">Actions</a></h1>
<p>Second-generation cephalosporin antibiotic with drug structure characterized by a beta-lactam ring (like the penicillin structure),
         and inhibits cell wall synthesis of bacteria.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Effective against gram-positive and gram-negative bacteria including <i>staphylococci,</i> <i>beta-hemolytic streptococci,</i> <i>Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis</i>.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Upper and lower respiratory tract infections, skin and skin structure infections, urinary tract infections.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to cephalosporins and related antibiotics.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Renal impairment, seizures, pregnancy (category B), lactation.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Upper &amp; Lower Respiratory Tract Infections</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 200400 mg q12h taken 1 h a.c. or 2 h p.c.<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 1530 mg/kg/d divided q12h taken 1 h a.c. or 2 h p.c.<br/><br/><span class="indicationtitle">Skin &amp; Skin Structure Infections</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 200 mg q12h taken 1 h a.c. or 2 h p.c.<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 15 mg/kg/d divided q12h taken 1 h a.c. or 2 h p.c.<br/><br/><span class="indicationtitle">Urinary Tract Infections</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 200 mg q24h or 400 mg q12h taken 1 h a.c. or 2 h p.c.<br/><br/><span class="indicationtitle">Otitis Media</span><br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 30 mg/kg/d divided q12h taken 1 h a.c. or 2 h p.c.<br/><br/><span class="impairmenttitle">Renal Impairment</span><br/>Cl<sub>cr</sub> 1049 mL/min: reduce recommended dose by 50% or give standard dose q24h; <br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Reconstitute suspension by adding 30 or 60 mL of water to the 50- or 100-mL bottles, respectively, of dry mixture. Add the
            water in 2 portions and shake bottle after each portion.
         </li>
<li>Give at least 1 h before or 2 h after meals.</li>
<li>Give half of the normal dose if Cl<sub>cr</sub> lies between 10 and 49 mL/min.
         </li>
<li>Store suspension in a tightly closed container. Discard after 14 d.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> Headache. <span class="typehead">GI:</span> Nausea, vomiting, diarrhea, diaper rash, abdominal pain. <span class="typehead">Other:</span> Rash, candidiasis. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> May have prolonged bleeding time with <b>warfarin.</b>
<h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. <span class="typehead">Peak:</span> 4560 min. <span class="typehead">Distribution:</span> Distributes into middle ear fluid. <span class="typehead">Elimination:</span> Excreted in urine. <span class="typehead">Half-Life:</span> 0.780.85 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Take a careful history to determine previous hypersensitivity reaction to beta-lactam antibiotics (penicillins and cephalosporins)
            or to other allergens.
         </li>
<li>Discontinue drug and notify the physician immediately if allergic reaction occurs (e.g., hives, wheezing, rash, pruritus).</li>
<li>Inspect patient's mouth on a regular basis to detect superinfection (see Appendix F).</li>
<li>Rule out pseudomembranous enterocolitis (see Appendix F) if severe diarrhea accompanied by abdominal pain and fever occurs.
            Notify physician immediately.
         </li>
<li>Monitor kidney function throughout therapy with concurrent diuretic use.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Notify physician immediately of rash or any other allergic reaction.</li>
<li>Report loose stools or diarrhea promptly.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>